Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study

Zhou, Meirong; Wang, Shouman; Wan, Nengbin; Yuan, Songlin; Hu, Xiongqiang; Zhou, Wei; Qing, Bohua; Liu, Mingwen; Sun, Weihua; Fan, Peizhi; Wang, Jianguo; Cao, Hong; Xu, Haifan; Dai, Bin; Tang, Peizhi; Qian, Liyuan; Zhao, Xi; Xiao, Jun; Zhou, Huaiying; Hu, Jinhui; Ding, Li; Tripodi, Domenico; Zdenkowski, Nicholas; O’Keefe, Thomas J.; Sanchez, Alejandro Martin; Chen, Li; Zhang, Ping; Xu, Feng

Published in

AME Publishing, Annals of Translational Medicine, 24(10), p. 1387-1387, 2022

DOI: 10.21037/atm-22-6054

Tools

Export citation

Search in Google Scholar

Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study

Journal article published in 2022 by Meirong Zhou, Shouman Wang, Nengbin Wan, Songlin Yuan, Xiongqiang Hu, Wei Zhou, Bohua Qing, Mingwen Liu, Weihua Sun, Peizhi Fan, Jianguo Wang, Hong Cao, Haifan Xu, Bin Dai, Peizhi Tang and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving allowed

Upload

Policy details

Data provided by

Published in

Links

Tools

Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study